BlackBarn Capital Partners LP Increases Position in Privia Health Group, Inc. $PRVA

BlackBarn Capital Partners LP raised its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 13.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 750,000 shares of the company’s stock after acquiring an additional 86,603 shares during the period. Privia Health Group makes up 1.1% of BlackBarn Capital Partners LP’s portfolio, making the stock its 6th largest holding. BlackBarn Capital Partners LP owned approximately 0.62% of Privia Health Group worth $16,838,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. US Bancorp DE grew its stake in shares of Privia Health Group by 2.4% in the 1st quarter. US Bancorp DE now owns 18,487 shares of the company’s stock worth $415,000 after buying an additional 429 shares in the last quarter. Park Avenue Securities LLC grew its stake in shares of Privia Health Group by 3.6% in the 1st quarter. Park Avenue Securities LLC now owns 15,229 shares of the company’s stock worth $342,000 after buying an additional 532 shares in the last quarter. CWM LLC grew its stake in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after buying an additional 604 shares in the last quarter. Financial Management Professionals Inc. grew its stake in shares of Privia Health Group by 28.7% in the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company’s stock worth $76,000 after buying an additional 754 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of Privia Health Group by 113.1% in the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after buying an additional 1,521 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on PRVA shares. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday. JPMorgan Chase & Co. lifted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 28th. JMP Securities reissued a “market outperform” rating and issued a $29.00 price objective on shares of Privia Health Group in a research note on Monday, April 28th. Evercore ISI dropped their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, July 9th. Finally, Barclays lifted their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $28.00.

Privia Health Group Trading Up 3.1%

PRVA stock opened at $21.99 on Friday. Privia Health Group, Inc. has a 12 month low of $16.47 and a 12 month high of $26.09. The company has a 50-day moving average price of $20.94 and a 200 day moving average price of $22.71. The stock has a market cap of $2.70 billion, a PE ratio of 199.93, a P/E/G ratio of 3.09 and a beta of 0.80.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The firm had revenue of $521.15 million for the quarter, compared to analysts’ expectations of $466.97 million. During the same period in the prior year, the firm posted $0.19 earnings per share. Privia Health Group’s revenue for the quarter was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. Sell-side analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.